{"database": "openregs", "table": "documents", "rows": [["FDA-2024-N-1111-0003", "FDA", "FDA-2024-N-1111", "PRIA Ref 1 - U.S Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, \"Guidelines for Regulatory Impact Analysis,\" 2016.", "Supporting & Related Material", "Background Material", "2024-08-19T04:00:00Z", 2024, 8, null, null, "2024-08-19T13:07:43Z", null, 0, 0, "090000648664c5f8"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-N-1111-0003"], "units": {}, "query_ms": 11.825471883639693, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}